Prevalence of stroke in Bangladesh: A systematic review and meta-analysis

IF 2 4区医学 Q3 NEUROSCIENCES

Journal of Stroke & Cerebrovascular Diseases Pub Date : 2024-09-19 DOI:10.1016/j.jstrokecerebrovasdis.2024.108017

Tonmoy Alam Shuvo, Asma-Ul- Hosna, Kabir Hossain, Sorif Hossain

{"title":"Prevalence of stroke in Bangladesh: A systematic review and meta-analysis","authors":"Tonmoy Alam Shuvo, Asma-Ul- Hosna, Kabir Hossain, Sorif Hossain","doi":"10.1016/j.jstrokecerebrovasdis.2024.108017","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Stroke is a major health concern in Bangladesh due to its high incidence and effect on rates of morbidity and death. The morbidity due to stroke in Bangladesh is indeed increasing. This study aimed to find the pooled prevalence of stroke in Bangladesh.</div></div><div><h3>Methods</h3><div>An extensive search was conducted using PubMed, MEDLINE, and Google Scholar databases. I<sup>2</sup> and Q-tests were employed to evaluate the heterogeneity. A random-effects model and subgroup analysis were performed due to the significant heterogeneity. We used Egger's test and funnel plot to look at publication bias. Meta-regression was carried out to analyze how different study variables influenced the effect estimates and to explore sources of heterogeneity across studies. The GRADE approach was used to evaluate the overall quality of the evidence, and the Joanna Briggs Institute tool was used to assess the risk of bias. Sensitivity analysis was conducted to evaluate the robustness of the meta-analysis results. STATA version 17 was used for analysis.</div></div><div><h3>Results</h3><div>We selected eleven (n = 1577293) studies that met the inclusion criteria for the final synthesis. In Bangladesh, the overall pooled prevalence of stroke was 1.10 % (95 % CI: 0.70–1.51). Subgroup analysis showed that the prevalence of stroke was 1.14 % (95 % CI: 0.58–1.70) from 2005 to 2014 and 1.04 % (95 % CI: 0.40–1.68) from 2015 to 2024.</div></div><div><h3>Conclusion</h3><div>Stroke prevalence in Bangladesh is significantly high. The country's healthcare system faces adequate stroke prevention and treatment challenges. Improving healthcare services and public health education are crucial to addressing this increasing public health issue.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"33 12","pages":"Article 108017"},"PeriodicalIF":2.0000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke & Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1052305724004622","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Stroke is a major health concern in Bangladesh due to its high incidence and effect on rates of morbidity and death. The morbidity due to stroke in Bangladesh is indeed increasing. This study aimed to find the pooled prevalence of stroke in Bangladesh.

Methods

An extensive search was conducted using PubMed, MEDLINE, and Google Scholar databases. I² and Q-tests were employed to evaluate the heterogeneity. A random-effects model and subgroup analysis were performed due to the significant heterogeneity. We used Egger's test and funnel plot to look at publication bias. Meta-regression was carried out to analyze how different study variables influenced the effect estimates and to explore sources of heterogeneity across studies. The GRADE approach was used to evaluate the overall quality of the evidence, and the Joanna Briggs Institute tool was used to assess the risk of bias. Sensitivity analysis was conducted to evaluate the robustness of the meta-analysis results. STATA version 17 was used for analysis.

Results

We selected eleven (n = 1577293) studies that met the inclusion criteria for the final synthesis. In Bangladesh, the overall pooled prevalence of stroke was 1.10 % (95 % CI: 0.70–1.51). Subgroup analysis showed that the prevalence of stroke was 1.14 % (95 % CI: 0.58–1.70) from 2005 to 2014 and 1.04 % (95 % CI: 0.40–1.68) from 2015 to 2024.

Conclusion

Stroke prevalence in Bangladesh is significantly high. The country's healthcare system faces adequate stroke prevention and treatment challenges. Improving healthcare services and public health education are crucial to addressing this increasing public health issue.

查看原文本刊更多论文

孟加拉国的中风发病率：系统回顾与荟萃分析。

背景：中风是孟加拉国的一个主要健康问题，因为它发病率高，影响发病率和死亡率。孟加拉国的中风发病率确实在不断上升。本研究旨在了解孟加拉国中风的总体发病率：方法：使用 PubMed、MEDLINE 和 Google Scholar 数据库进行了广泛搜索。采用 I2 和 Q 检验来评估异质性。由于存在显著的异质性，我们采用了随机效应模型和亚组分析。我们使用 Egger 检验和漏斗图来观察发表偏倚。我们进行了元回归分析，以分析不同研究变量对效应估计值的影响，并探讨不同研究间异质性的来源。使用 GRADE 方法评估证据的整体质量，并使用乔安娜-布里格斯研究所的工具评估偏倚风险。进行了敏感性分析，以评估荟萃分析结果的稳健性。分析使用 STATA 17 版本：我们选择了 11 项（n = 1577293）符合纳入标准的研究进行最终综合。在孟加拉国，中风的总体合并患病率为 1.10%（95% CI：0.70-1.51）。亚组分析显示，2005 年至 2014 年的中风患病率为 1.14%（95% CI：0.58-1.70），2015 年至 2024 年为 1.04%（95% CI：0.40-1.68）：结论：孟加拉国的中风发病率非常高。结论：孟加拉国的脑卒中发病率非常高，该国的医疗保健系统面临着足够的脑卒中预防和治疗挑战。改善医疗服务和公共卫生教育对解决这一日益严重的公共卫生问题至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Stroke & Cerebrovascular Diseases Medicine-Surgery

CiteScore

5.00

自引率

4.00%

发文量

583

审稿时长

62 days

期刊介绍： The Journal of Stroke & Cerebrovascular Diseases publishes original papers on basic and clinical science related to the fields of stroke and cerebrovascular diseases. The Journal also features review articles, controversies, methods and technical notes, selected case reports and other original articles of special nature. Its editorial mission is to focus on prevention and repair of cerebrovascular disease. Clinical papers emphasize medical and surgical aspects of stroke, clinical trials and design, epidemiology, stroke care delivery systems and outcomes, imaging sciences and rehabilitation of stroke. The Journal will be of special interest to specialists involved in caring for patients with cerebrovascular disease, including neurologists, neurosurgeons and cardiologists.